Answers are grounded in this paper and cite their sources.
Patient-reported outcomes (PROs) are often used by clinicians to evaluate patient response to specialty medications used to treat multiple sclerosis (MS) and rheumatologic conditions. Identifying associations among PROs and patient characteristics could inform patient-centered treatment monitoring.
No takes yet. Share an insight, caveat, or question.
Bryan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: